Organon Management

Management criteria checks 3/4

Organon's CEO is Kevin Ali, appointed in Jun 2021, has a tenure of 3.5 years. total yearly compensation is $14.83M, comprised of 8.4% salary and 91.6% bonuses, including company stock and options. directly owns 0.056% of the company’s shares, worth $2.11M. The average tenure of the management team and the board of directors is 3.5 years and 3.5 years respectively.

Key information

Kevin Ali

Chief executive officer

US$14.8m

Total compensation

CEO salary percentage8.4%
CEO tenure3.5yrs
CEO ownership0.06%
Management average tenure3.5yrs
Board average tenure3.5yrs

Recent management updates

Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

May 29
Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

Recent updates

Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price

Dec 13
Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price

Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)

Nov 13

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 04
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis

Sep 19

These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Sep 13
These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Organon & Co.: Cheap With Caveats

Aug 22

Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Aug 09
Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Aug 07
Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Jul 30

Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

May 29
Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

May 10
Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

Four Reasons Why Organon Stock Is A Good Buy

May 07

Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Apr 21
Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Organon Stock Is Still Worth A Look

Feb 24

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Feb 19
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last

Feb 16

Organon: What I'm Looking For In This 8% Yield In 2024

Jan 03

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

Dec 19

Organon: It's Darkest Before The Dawn

Nov 30

Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace

Nov 07

Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Nov 05
Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Organon: The Federal Reserve Black Swan (Rating Upgrade)

Oct 04

6% Yield And Significantly Undervalued: A Closer Look At Organon

Sep 10

Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk

Aug 10

Organon & Co.: A Tough Spot To Be In Right Now

Jul 16

Organon goes ex-dividend tomorrow

Feb 23

Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 19
Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Is There Anything Organic Or Interesting About Organon?

Feb 07

Organon goes ex-dividend tomorrow

Nov 09

Organon's (NYSE:OGN) Dividend Will Be $0.28

Nov 08
Organon's (NYSE:OGN) Dividend Will Be $0.28

CEO Compensation Analysis

How has Kevin Ali's remuneration changed compared to Organon's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$1b

Jun 30 2024n/an/a

US$1b

Mar 31 2024n/an/a

US$1b

Dec 31 2023US$15mUS$1m

US$1b

Sep 30 2023n/an/a

US$585m

Jun 30 2023n/an/a

US$754m

Mar 31 2023n/an/a

US$746m

Dec 31 2022US$14mUS$1m

US$917m

Sep 30 2022n/an/a

US$1b

Jun 30 2022n/an/a

US$1b

Mar 31 2022n/an/a

US$1b

Dec 31 2021US$19mUS$1m

US$1b

Compensation vs Market: Kevin's total compensation ($USD14.83M) is above average for companies of similar size in the US market ($USD6.67M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


CEO

Kevin Ali (64 yo)

3.5yrs

Tenure

US$14,832,272

Compensation

Mr. Kevin Ali is Chief Executive Officer and Director of Organon & Co. since June 2, 2021. Mr. Ali served as the President of Global Enterprise Portfolio Strategy at Merck & Co., Inc. from 2019 to 2021 and...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Ali
CEO & Director3.5yrsUS$14.83m0.056%
$ 2.1m
Matthew Walsh
Executive VP & CFO3.5yrsUS$5.21m0.036%
$ 1.3m
Kirke Weaver
Executive VP1.9yrsUS$3.19m0.011%
$ 425.1k
Susanne Fiedler
Executive VP & Chief Commercial Officer3.9yrsUS$3.84m0.021%
$ 774.3k
Joseph Morrissey
Executive VP and Head of Manufacturing & Supply3.5yrsUS$3.74m0.017%
$ 625.2k
Rachel Stahler
Executive VP & Chief Information Officer3.5yrsno data0.019%
$ 731.8k
Jennifer Halchak
Head of Investor Relations3.9yrsno datano data
Susan O'Neal
Chief Ethics & Compliance Officerno datano datano data
Rebecca Edwards
Chief Communications Officerno datano datano data
Daniel Karp
Executive Vice President of Corporate Developmentno datano data0.0075%
$ 282.4k
Aaron Falcione
Executive VP & Chief Human Resources Officer3.5yrsno data0.013%
$ 476.1k
Vittorio Nisita
Executive VP & Head of Global Business Services3.5yrsno data0.0096%
$ 360.8k

3.5yrs

Average Tenure

56yo

Average Age

Experienced Management: OGN's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin Ali
CEO & Director3.5yrsUS$14.83m0.056%
$ 2.1m
Carrie Cox
Independent Chairman of the Board3.5yrsUS$450.00kno data
Robert Essner
Independent Director3.5yrsUS$335.00kno data
Rochelle Lazarus
Independent Director3.5yrsUS$320.00k0.00025%
$ 9.4k
R. Alan Ezekowitz
Independent Director3.5yrsUS$330.00kno data
Helene Gayle
Independent Director3.5yrsUS$320.00kno data
Shalini Sharp
Independent Director3.5yrsUS$345.00k0%
$ 0
Philip Ozuah
Independent Director3.5yrsUS$320.00kno data
Cynthia Patton
Independent Director3.5yrsUS$330.00kno data
Grace Whiteford
Independent Director3.5yrsUS$320.00k0%
$ 0
Deborah Leone
Independent Director3.5yrsUS$330.00k0%
$ 0

3.5yrs

Average Tenure

64yo

Average Age

Experienced Board: OGN's board of directors are considered experienced (3.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Organon & Co. is covered by 15 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Balaji PrasadBarclays
Balaji PrasadBarclays
Navann Ty DietschiBNP Paribas Exane